Company performance
Add to research
Current Price
as of Jun 18, 2025$2.33
P/E Ratio
N/A
Market Cap
$467.75M
Description
Add to research
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany.
Metrics
Add to research
Overview
- HQBerlin, BE
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerATAI
- Price$2.33+4.95%
Trading Information
- Market cap$467.75M
- Float68.28%
- Average Daily Volume (1m)2,743,701
- Average Daily Volume (3m)2,135,921
- EPS-$0.93
Company
- Revenue$0.31M
- Rev growth (1yr)N/A
- Net income-$26.43M
- Gross margin86.11%
- EBITDA margin-1,225.34%
- EBITDA-$19.05M
- EV$160.71M
- EV/Revenue521.80
- P/EN/A
- P/S1,333.48
- P/B3.06
- Debt/Equity19.05
Documents
Add to research
SEC Filings
Factset Street Account
Factset